期刊文献+

高尔基体磷蛋白3基因过表达对胃癌细胞增殖的影响 被引量:1

GOLPH3 gene overexpression promotes proliferation of gastric cancer cells
暂未订购
导出
摘要 目的:观察高尔基体磷蛋白3(Golgi phosphoprotein 3,GOLPH3)基因过表达后胃癌细胞增殖的情况.方法:构建GOLPH3基因过表达重组慢病毒颗粒pGC-FU-GOLPH3-EGFP,用慢病毒法感染胃癌细胞株SGC-7901,利用荧光显微镜(Axiovert200)观察感染后细胞内EGFP表达的情况,利用流式细胞技术检测慢病毒的感染效率,采用实时荧光定量PCR(quantitative real-time polymerase chain reaction)和蛋白质印迹(Western blot)技术分别在基因水平和蛋白水平检测GOLPH3在SGC-7901-GOLPH3组(感染pGC-FU-GOLPH3-EGFP质粒的SGC-7901)、SGC-7901-empty-vector组(感染pGC-FU-EGFP质粒的SGC-7901)和SGC-7901-blank组(未感染慢病毒的SGC-7901)的表达水平;以四唑蓝比色法(MTT)检测GOLPH3基因过表达后胃癌细胞增殖的情况;Western blot技术检测胃癌细胞SGC-7901稳转细胞株中哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)和磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)的表达水平.结果:建立了慢病毒感染率接近100%的胃癌细胞株SGC-7901,在体外能够长期稳定表达绿色荧光蛋白;SGC-7901-GOLPH3组GOLPH3mRNA和蛋白表达水平明显高于SGC-7901-e m p t y-v e c t o r组和S G C-7901-b l a n k组(均P<0.05);MTT法结果显示胃癌细胞GOLPH3基因过表达后,增殖能力明显增强,与SGC-7901-empty-vector组和SGC-7901-blank组相比差别有统计学意义(均P<0.05);SGC-7901-GOLPH3组、SGC-7901-empty-vector组和SGC-7901-blank组中mTOR总蛋白的表达无明显变化,而SGC-7901-GOLPH3组p-mTOR蛋白表达量较SGC-7901-empty-vector组和SGC-7901-blank组明显升高,与两对照组相比,上调GOLPH3能明显促进SGC-7901-GOLPH3组p-mTOR蛋白的表达(均P<0.05).结论:GOLPH3基因可能是通过上调mTOR信号通路中mTOR蛋白磷酸化水平来促进胃癌细胞增殖. AIM: To observe the effect of GOLPH3 gene overexpression on the proliferation of gastric cancer cells. METHODS: The lentivirus containing the GOLPH3 gene was infected into gastric cancer cells, fluorescence microscopy was used to detect the expression of EGFP, and flow cytometry was applied to verify the infection efficiency. GOLPH3 overexpression was verified by quantitative realime PCR (at the mRNA level) and Western blot (at the protein level). The expression of mTOR and p-mTOR proteins was detected by Western blot, and cell proliferation was assessed by MTT assay.RESULTS: Gastric cancer cells expressing high levels of EGFP were successfully obtained, with an infection rate of 100%. GOLPH3 expression was significantly up-regulated in SGC-7901 cells infected with the lentivirus containing the GOLPH3 gene compared with SGC-7901 ceils transduced with the empty vector or noninfected SGC-7901 cells (P 〈 0.05 for both). MTT assay showed that up-regulated GOLPH3 could significantly enhance the proliferation of gastric cancer cells (P 〈 0.05). Although the mTOR protein expression did not significantly differ between different groups of cells, but p-mTOR protein expression was enhanced in SGC-7901 cells infected with the lentivirus containing the GOLPH3 gene compared with control cells (P 〈 0.05), suggesting that up-regulated GOLPH3 could promote the protein expression of p-mTOR in SGC-7901 cells. CONCLUSION: GOLPH3 gene overexpression could promote the proliferation of gastric cancer cells by up-regulating the expression of p-roTOR in SGC-7901 cells.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第12期1669-1675,共7页 World Chinese Journal of Digestology
基金 广西科学研究与技术开发计划基金资助项目 No.桂科攻1140003A-13~~
关键词 胃癌细胞株SGC-7901 高尔基体磷蛋白3 细胞增殖 哺乳动物雷帕霉素靶蛋白 SGC-7901 Golgi phosphoprotein 3 Cellproliferation Mammalian target of rapamycin
  • 相关文献

参考文献29

  • 1Brenner B,Hoshen MB,Purim O,David MB,Ashkenazi K,Marshak G,Kundel Y,Brenner R,Morgenstern S,Halpern M,Rosenfeld N,Chajut A,Niv Y,Kushnir M.MicroRNAs as a potential prognostic factor in gastric cancer.World J Gastroenterol 2011;17:3976-3985.
  • 2Jemal A,Bray F,Center MM,Ferlay J,Ward E,Forman D.Global cancer statistics.CA Cancer J Clin 2011;61:69-90.
  • 3Lee KW,Park SR,Oh DY,Park YI,Khosravan R,Lin X,Lee SY,Roh EJ,Valota O,Lechuga MJ,Bang YJ.Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer.Invest New Drugs 2013;31:1547-1558.
  • 4Scott KL,Kabbarah O,Liang MC,Ivanova E,Anagnostou V,Wu J,Dhakal S,Wu M,Chen S,Feinberg T,Huang J,Saci A,Widlund HR,Fisher DE,Xiao Y,Rimm DL,Protopopov A,Wong KK,Chin L.GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.Nature 2009;459:1085-1090.
  • 5Hu BS,Hu H,Zhu CY,Gu YL,Li JP.Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer.Tumour Biol 2013;34:515-520.
  • 6Bell AW,Ward MA,Blackstock WP,Freeman HN,Choudhary JS,Lewis AP,Chotai D,Fazel A,Gushue JN,Paiement J,Palcy S,Chevet E,Lafrenière-Roula M,Solari R,Thomas DY,Rowley A,Bergeron JJ.Proteomics characterization of abundant Golgi membrane proteins.J Biol Chem 2001;276:5152-5165.
  • 7Dippold HC,Ng MM,Farber-Katz SE,Lee SK,Kerr ML,Peterman MC,Sim R,Wiharto PA,Galbraith KA,Madhavarapu S,Fuchs GJ,Meerloo T,Farquhar MG,Zhou H,Field SJ.GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding.Cell 2009;139:337-351.
  • 8Schmitz KR,Liu J,Li S,Setty TG,Wood CS,Burd CG,Ferguson KM.Golgi localization of glycosyltransferases requires a Vps74p oligomer.Dev Cell 2008;14:523-534.
  • 9Wood CS,Schmitz KR,Bessman NJ,Setty TG,Ferguson KM,Burd CG.PtdIns4P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking.J Cell Biol 2009;187:967-975.
  • 10D'Angelo G,Vicinanza M,Di Campli A,De Matteis MA.The multiple roles of PtdIns(4)P -- not just the precursor of PtdIns(4,5)P2.J Cell Sci 2008;121:1955-1963.

二级参考文献22

  • 1Bai X, Jiang Y. Key factors in mTOR regulation. Cell Mol Life Sci, 2010,67:239-253.
  • 2Helliwell SB, Wagner P, Kunz J, et al. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Biol Cell, 1994,5 : 105-118.
  • 3Menon S, Manning BD. Common corruption of the mTOR signaling network in human tumors. Oncogene, 2008,27 Suppl 2: S43-51.
  • 4Sparks CA, Guertin DA. Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oneogene, 2010, 29: 3733-3744.
  • 5Meric-Bernstam F, Gonzalez-Angulo AM. Targeting the mTOR signaling network for cancer therapy. J Clin Onco|, 2009,27 : 2278-2287.
  • 6Bjornsti MA, Houghton PJ. The TOR pathway:a target for cancer therapy. Nat Rev Cancer, 2004,4:335-348.
  • 7Slattery ML, Herrick J, Lundgreen A, et al. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: roTOR, PTEN, STK1, RPKAA1, PRKAG2, TSC1, TSC2, PI3K, and Aktl. Carcinogenesis, 2010,31 : 1604-1611.
  • 8Pencreach E, Gu6rin E, Nicolet C, et al. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-lalpha axis. Clin Cancer Res, 2009, 15:1297-1307.
  • 9Guba M, yon Breitenbuch P, Steinbauer M, ct al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med, 2002, 8:128-135.
  • 10Lang SA, Gaumann A, Koehl GE,et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer, 2007,120:1803-1810.

共引文献8

同被引文献18

  • 1侯晓玮,王雅杰,王梅,朱玉兆,李永梅.同源异型盒基因HOXD10在乳腺癌组织中的表达及其临床病理意义[J].中国癌症杂志,2007,17(6):448-452. 被引量:6
  • 2潘洪明,费洪新,杜静平,陈正华,张涛.人胃癌顺铂耐药细胞系的建立过程[J].世界华人消化杂志,2007,15(18):2009-2013. 被引量:9
  • 3Bernards N, Creemers GJ, Nieuwenhuijzen GA, et al. No improvement in median survival for patients with metastatic gastric cancer despite in- creased use of chemotherapy [ J]. Ann Oncol, 2013, 24(12) : 3056- 3060.
  • 4Cardoso R, Coburn N, Seevaratnam R, et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer [J]. Gastric Cancer, 2012, 15(1): 19-26.
  • 5Zhang KG, Qin CY, Wang HQ, et al. The effect of TRAIL on the ex- pression of muhidrug resistant genes MDR1, LRP and GST-'rr in drug- resistant gastric cancer cell SGC7901/VCR [ J]. Hepatogastroenterolo- zv. 2011. 59(120): 2672-2676.
  • 6Grier DG, Thompson A, Kwasniewska A, et al. The pathophysiology of HOX genes and their role in cancer [ J]. J Pathol, 2005, 205 (2) : 154-171.
  • 7Ansari KI, Hussain I, Kasiri S, et al. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involve- ment of histone methylases MLL3 and MLIA [ J]. J Mol Endocrinol, 2012, 48(1) : 61-75.
  • 8Pilato B, Pinto R, De Summa S, et al. HOX gene methylation status a- nalysis in patients with hereditary breast cancer [ J]. J Hum Genet, 2013, 58(1): 51-53.
  • 9Sun L, Yan W, Wang Y, et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10 [J]. Brain Res, 2011, 1389(3) : 9-18.
  • 10Hallett RM, Huang C, Motazedian A, et al. Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy [ J]. Oncotar- get, 2015, 6(9): 7040-7052.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部